# Enhanced Colon Regeneration in Ulcerative Colitis via Mesenchymal Stem Cell Medium and 17‐β Estradiol

**Authors:** Zahra Bakhtiary, Zahra Hosseinpour, Seyyed Meysam Abtahi Froushani

PMC · DOI: 10.1002/iid3.70387 · Immunity, Inflammation and Disease · 2026-02-25

## TL;DR

This study explores how mesenchymal stem cell medium, especially when treated with estradiol, can improve colon healing in rats with ulcerative colitis.

## Contribution

The novel use of estradiol-treated mesenchymal stem cell medium to enhance colon regeneration in ulcerative colitis is introduced.

## Key findings

- MSC and E2-treated MSC groups showed reduced inflammation and disease activity in UC rats.
- Histopathological analysis showed improved colon tissue regeneration in MSC-treated groups.
- E2-treated MSC medium was particularly effective in reducing inflammatory markers.

## Abstract

Ulcerative colitis (UC), a form of inflammatory bowel disease (IBD), increases the risk of colorectal cancer. This study investigates the potential of conditioned medium from mesenchymal stem cells (CMm) treated with 17‐beta‐estradiol (E2) to enhance colon regeneration in UC‐affected rats.

Bone marrow‐derived MSCs from male Wistar rats were cultured with 100 nM E2 for 24 h. UC was induced in three groups: colitis (C), mesenchymal stem cells (MSC), and MSCs + estradiol (MSC + E2). Each group received intraperitoneal injections of 200 µL CMm derived from 2 × 106 cells or E2‐treated CMm three times postinduction. The study evaluated disease activity index (DAI), myeloperoxidase (MPO) levels, nitric oxide (NO), and pro‐inflammatory cytokines (TNF‐α, IL‐1β, IL‐6) in colon tissues, alongside histopathological assessments.

Results showed significant improvements in DAI and reductions in MPO, NO, and cytokine levels in MSC and MSC + E2 groups compared to the C group. Histopathological analysis revealed enhanced colon tissue regeneration in these groups.

These findings suggest that CMm, particularly with E2, may facilitate colonic healing and mitigate inflammation in UC.

A notable decrease in disease symptoms, oxidant levels, and mRNA expression of inflammatory factors was observed in the groups treated with the culture medium of MSCs, especially in those receiving E2.Histopathological analysis revealed a significant enhancement in colonic tissue regeneration in both groups administered culture medium after colitis induction.

A notable decrease in disease symptoms, oxidant levels, and mRNA expression of inflammatory factors was observed in the groups treated with the culture medium of MSCs, especially in those receiving E2.

Histopathological analysis revealed a significant enhancement in colonic tissue regeneration in both groups administered culture medium after colitis induction.

## Linked entities

- **Proteins:** TNF (tumor necrosis factor), IL1B (interleukin 1 beta), IL6 (interleukin 6)
- **Chemicals:** 17-β Estradiol (PubChem CID 154274), nitric oxide (PubChem CID 145068)
- **Diseases:** ulcerative colitis (MONDO:0005101), colorectal cancer (MONDO:0005575)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Hgf (hepatocyte growth factor) [NCBI Gene 24446] {aka HPTA}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 83785] {aka VEGF-A, VEGF111, VEGF164, VPF, Vegf}, Il17a (interleukin 17A) [NCBI Gene 301289] {aka CTLA-8, IL-17, IL-17A, Il17}, Il10 (interleukin 10) [NCBI Gene 25325] {aka IL10X, If2a}, Kitlg (KIT ligand) [NCBI Gene 60427] {aka Kitl, Mgf, SCF}, Igf2 (insulin-like growth factor 2) [NCBI Gene 24483] {aka IGFII, RNIGF2}, Ccr2 (C-C motif chemokine receptor 2) [NCBI Gene 60463], Esr1 (estrogen receptor 1) [NCBI Gene 24890] {aka ER-alpha, Esr, RNESTROR}, Il6 (interleukin 6) [NCBI Gene 24498] {aka ILg6, Ifnb2}, Crp (C-reactive protein) [NCBI Gene 25419] {aka Aa1249, Ab1-341, Ab2-196, Ac1-114, Ac1262, Ac2-069}, Igf1 (insulin-like growth factor 1) [NCBI Gene 24482] {aka IGF}, Cxcl12 (C-X-C motif chemokine ligand 12) [NCBI Gene 24772] {aka Sdf1}, Pik3cb (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta) [NCBI Gene 85243], Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, Mpo (myeloperoxidase) [NCBI Gene 303413], Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Ephb1 (Eph receptor B1) [NCBI Gene 24338] {aka Ephb2, Erk, elk}, Cxcr4 (C-X-C motif chemokine receptor 4) [NCBI Gene 60628], Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 24383] {aka BARS-38, Gapd}, Esr2 (estrogen receptor 2) [NCBI Gene 25149] {aka ER-beta, ERbeta, Erb2}
- **Diseases:** IBD (MESH:D015212), collagenous colitis (MESH:D046729), loss of appetite (MESH:D001068), MS (MESH:D009103), fistula (MESH:D005402), necrosis (MESH:D009336), liver, kidney and skin disorders (MESH:D012868), UC (MESH:D003093), tissue damage (MESH:D017695), arthritis (MESH:D001168), RA (MESH:D001172), colorectal cancer (MESH:D015179), Crohn's disease (MESH:D003424), collagenosis (MESH:C565687), Colitis (MESH:D003092), weight loss (MESH:D015431), rheumatoid factor (MESH:D001171), weight gain (MESH:D015430), bleeding (MESH:D006470), chronic diarrhea (MESH:D003967), tumorigenesis (MESH:D063646), abscesses (MESH:D000038), CDI (MESH:D012090), Chronic inflammation (MESH:D007249), pain (MESH:D010146), abdominal pain (MESH:D015746), eosinophilia (MESH:D004802)
- **Chemicals:** CO2 (MESH:D002245), PBS (MESH:D007854), formalin (MESH:D005557), glucose (MESH:D005947), ether (MESH:D004986), DMSO (MESH:D004121), ROS (MESH:D017382), sulfuric acid (MESH:C033158), hydrogen peroxide (MESH:D006861), DMEM (-), prednisolone (MESH:D011239), H&amp;E (MESH:D006371), atorvastatin (MESH:D000069059), sulfanilamide (MESH:D000077145), sodium sulfate (MESH:C012036), phosphoric acid (MESH:C030242), acetic acid (MESH:D019342), NO (MESH:D009569), Paraffin (MESH:D010232), 5-aminosalicylic acid (MESH:D019804), 17-beta Estradiol (MESH:D004958), EDTA (MESH:D004492)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12933408/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12933408/full.md

## References

51 references — full list in the complete paper: https://tomesphere.com/paper/PMC12933408/full.md

---
Source: https://tomesphere.com/paper/PMC12933408